Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Oliver & Co who wrote (2937)	11/21/1997 6:38:00 PM
From: margie	Read Replies (4) \| Respond to of 6136

There was an article in Barron's this past weekend that mentioned that the "Prudent Bear" mutual fund is short Agouron. And Jesse Eisenger has quoted "an anonymous influential hedge fund manager" who is short the stock. Some institution could be doing it to hedge a large long position. Who knows? I doubt if many follow the company as we do, or know what a great success Viracept has been for AIDS patients, or know that Viracept's market share keeps increasing, while Merck's decrease. The open interest last night for Nov 42 1/2 puts was 4331. So they may have rolled them over. It doesn't mean they'll keep them there. Anyone know how to check?